Bharat Biotech’s Covaxin Shows 78 Percent Efficacy In Phase 3 Analysis
Photo courtesy: Swarajyamag
The final phase 3 analysis of Covaxin, the Covid-19 jab developed by Bharat Biotech, has shown the efficacy of 78 per cent in preventing symptomatic coronavirus caused disease, a report said.
.
Read more at: https://swarajyamag.com/news-brief/bharat-biotechs-covaxin-shows-78-percent-efficacy-in-phase-3-analysis
.
- 31 May 2021
- WerIndia
Loading ...
